The Shilla Seoul, Seoul, Korea

AIRIS2024: Use of AI in Medical Product Development organized by the US FDA and Ministry of Food and Drug Safety of the Republic of Korea

February 27, 2024

Rhino Health Co-founder and CEO Dr. Ittai Dayan participated in AIRIS 2024, a premier conference co-organized by the U.S. FDA and Korea’s Ministry of Food and Drug Safety. Held in Seoul, the event focused on leveraging artificial intelligence (AI) for medical product development. Dr. Dayan presented on the transformative role of Federated Computing in unlocking real-world data for regulatory processes.

He joined a distinguished panel with experts Bruce Church, Kyu Hwan Jung, Hwiyoung Kim, and Joseph Lehár, moderated by FDA’s Dr. B. Y. MiRa Jacobs, PhD. Discussions centered on advancing global regulatory standards and the integration of AI into healthcare to ensure safe and effective medical innovations.

To explore how the Rhino Federated Computing Platform can accelerate edge computing and federated learning initiatives, contact Rhino Health at contact@rhinohealth.com.

For more details, visit the AIRIS 2024 official website.

Build your Federated Network